These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8600508)
1. Effects of continuous low-dose-rate brachytherapy on the rectum of the rat. Armour EP; White JR; DeWitt CC; Corry PM; Martinez A Radiat Res; 1996 Apr; 145(4):474-80. PubMed ID: 8600508 [TBL] [Abstract][Full Text] [Related]
2. [Chronic radiation sequelae in the rat rectum following intracavitary irradiation with different doses]. Kiszel Z; Spiethoff A; Trott KR Strahlentherapie; 1985 Jun; 161(6):348-53. PubMed ID: 4012815 [TBL] [Abstract][Full Text] [Related]
3. Pulsed low dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Armour EP; White JR; Armin A; Corry PM; Coffey M; DeWitt C; Martinez A Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):825-34. PubMed ID: 9240652 [TBL] [Abstract][Full Text] [Related]
4. The effect of irradiated volume on the chronic radiation damage of the rat large bowel. Trott KR; Tamou S; Sassy T; Kiszel Z Strahlenther Onkol; 1995 Jun; 171(6):326-31. PubMed ID: 7597618 [TBL] [Abstract][Full Text] [Related]
5. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer. Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604 [TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915 [TBL] [Abstract][Full Text] [Related]
8. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources. Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809 [TBL] [Abstract][Full Text] [Related]
9. Normal tissue reactions to high dose-rate intracavitary irradiation of the vagina with different fractionation schedules and dose levels. Himmelmann A; Notter G; Turesson I Strahlentherapie; 1985 Mar; 161(3):163-7. PubMed ID: 3975951 [TBL] [Abstract][Full Text] [Related]
10. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [TBL] [Abstract][Full Text] [Related]
11. Relative biological effectiveness of 241Am relative to 192Ir for continuous low-dose-rate irradiation of BA1112 rat sarcomas. Morton J; Yabuki H; Porter EA; Rockwell S; Nath R Radiat Res; 1989 Sep; 119(3):478-88. PubMed ID: 2772139 [TBL] [Abstract][Full Text] [Related]
12. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy. Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445 [TBL] [Abstract][Full Text] [Related]
14. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766 [TBL] [Abstract][Full Text] [Related]
15. Proctitis cystica profunda and radiation fibrosis in the rectum of the female Wistar rat after X irradiation: a histopathological study. Hubmann FH J Pathol; 1982 Nov; 138(3):193-204. PubMed ID: 7131133 [TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
17. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281 [TBL] [Abstract][Full Text] [Related]
18. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793 [TBL] [Abstract][Full Text] [Related]
19. Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy. Guerrero M; Li XA Phys Med Biol; 2006 Aug; 51(16):4063-71. PubMed ID: 16885624 [TBL] [Abstract][Full Text] [Related]
20. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study. Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]